Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization: Nandita Vijayasimha, Bengaluru Wednesday, October 9, 2024, 08:00 Hrs [IST] ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

DelveInsight's CD47 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

Faced with a moribund share sale outlook and emboldened by their growing recognition on the global stage, some Chinese ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

The World Health Organization (WHO) has validated Timor-Leste for having eliminated lymphatic filariasis (LF) as a public ...

The UK High Court has ruled that two GSK respiratory syncytial virus (RSV) vaccine patents are invalid in an action involving ...

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Lenacapavir, is being celebrated as a major advancement in the field. This followed new study results that showed a 96 per ...